Early Use of Dinutuximab Beta in Patients with High-Risk Neuroblastoma

Neuroblastoma is the most common extracranial solid tumor in children, accounting for 15% of all pediatric cancer deaths. High-risk neuroblastoma (HRNB) is a particularly difficult-to-treat form of the disease that requires aggressive multimodality therapy, including induction chemotherapy, consolid...

Descripción completa

Detalles Bibliográficos
Autores principales: Spasov, Neofit, Spasova, Mariya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235958/
https://www.ncbi.nlm.nih.gov/pubmed/34239748
http://dx.doi.org/10.1155/2021/6610955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235958/
https://www.ncbi.nlm.nih.gov/pubmed/34239748
http://dx.doi.org/10.1155/2021/6610955

Ejemplares similares